Literature DB >> 19629313

Ambulatory blood pressure monitoring and cardiovascular risk in resistant hypertensive women.

Monica Maria Ferreira Magnanini1, Armando da Rocha Nogueira, Marilia Sá Carvalho, Katia Vergetti Bloch.   

Abstract

BACKGROUND: Few studies have explored the prognostic value of ambulatory blood pressure (ABP) in resistant hypertensive patients, a high-risk group.
OBJECTIVE: To investigate the prognostic value of uncontrolled daytime ABP in resistant hypertensive women.
METHODS: We followed 382 resistant hypertensive women, aged 24-92 years, from a hypertension unit of a university hospital, for up to 8.9 years (mean 3.9). Patients were classified as controlled (office BP>140/90 mmHg and daytime ABP<135/85 mmHg) or uncontrolled (office BP>140/90 mmHg and daytime ABP >135/85 mmHg). We analyzed a combined endpoint, consisting of cardiovascular mortality, ischemic heart disease, stroke and nephropathy. Cox proportional hazard models were used to estimate the risk for cardiovascular events, adjusting for potential confounders.
RESULTS: The total event rate was 5.0 per 100 women-years. In the controlled and uncontrolled groups, the rates were 3.7 vs. 5.8 events respectively, p=0.06. The relative risks adjusted for age and current smoking status associated with a 10 mmHg increment in systolic ABP were greater than the ones associated with a 5 mmHg increment in diastolic ABP. Non-dipper patients had a higher risk for cardiovascular events than dipper patients (RR = 1.42 (0.87-2.32)), although this association had no statistical significance. Uncontrolled daytime blood pressure (yes/no) was a stronger independent risk factor, 1.67 (1.00-2.78).
CONCLUSIONS: There was a 67% increase in the risk of a cardiovascular event if daytime ambulatory blood pressure was uncontrolled in women with resistant hypertension. Therefore, it is mandatory to use ABP to evaluate control and to guide therapeutic strategies in resistant hypertensive patients.

Entities:  

Mesh:

Year:  2009        PMID: 19629313     DOI: 10.1590/s0066-782x2009000600012

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  7 in total

Review 1.  Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Authors:  Antonios A Lazaridis; Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

Review 2.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

3.  Evaluation of biochemical, hematological, and thyroid function parameters in nondipper and dipper hypertensive patients.

Authors:  Ibrahim Akpinar; Nurcan Basar; Nihat Sen; Halil Lutfu Kisacik
Journal:  Wien Klin Wochenschr       Date:  2012-07-06       Impact factor: 1.704

4.  Ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Dimitrios Syrseloudis; Ioannis Andrikou; Eirini Andrikou; Kyriakos Dimitriadis; Christodoulos Stefanadis
Journal:  Int J Hypertens       Date:  2011-04-05       Impact factor: 2.420

5.  Benefits from treatment and control of patients with resistant hypertension.

Authors:  Michael Doumas; Vasilios Papademetriou; Stella Douma; Charles Faselis; Konstantinos Tsioufis; Eugene Gkaliagkousi; Konstantinos Petidis; Chrysanthos Zamboulis
Journal:  Int J Hypertens       Date:  2010-12-22       Impact factor: 2.420

6.  Prospective blood pressure measurement in renal transplant recipients.

Authors:  V G David; B Yadav; L Jeyaseelan; M N Deborah; S Jacob; S Alexander; S Varughese; G T John
Journal:  Indian J Nephrol       Date:  2014-05

Review 7.  Hypertension control in brazilian publications.

Authors:  Natália de Alencar Pinho; Angela Maria Geraldo Pierin
Journal:  Arq Bras Cardiol       Date:  2013-09       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.